National survey on dyslipidemic patients - PRYSME
Study identifier:NIS-CFR-DUM-2007/9
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Survey on time to lipid-lowering drug implementation on dyslipidemic patients in general practice.
Medical condition
Dyslipidemia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3655
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jun 2008
Primary Completion Date: -
Study Completion Date: 01 Jan 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Alain Castaigne
AstraZeneca
